Immunovant (IMVT) Return on Assets [ROA] (2019 - 2026)
Immunovant's Return on Assets [ROA] was -59.49% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 2.74 percentage points from -62.23% a year earlier but down 9.16 percentage points from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Return on Assets [ROA] (2019 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Return on Assets [ROA] at Immunovant came in at -58.34%, down 0.97 percentage points from FY2025.
- Return on Assets [ROA] has now declined for four consecutive fiscal years, with a five-year change of -17.17 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Assets [ROA] was -57.37% in FY2025 (-9.00 pp), -48.37% in FY2024 (-2.58 pp), -45.79% in FY2023 (-12.01 pp) and -33.78% in FY2022 (+7.39 pp).
- Quarterly Return on Assets [ROA] has moved between -81.72% (fiscal Q3 2025) and -24.82% (fiscal Q3 2022) over five years.
- Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters, with an average year-over-year change of -4.04 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q3 2026 (a gain of 24.95 percentage points); the worst was fiscal Q2 2024 (a drop of 39.47 percentage points).
- Per Business Quant data, IMVT's Return on Assets [ROA] in the three fiscal quarters before Q1 2027 was -50.32% (Q4 2026), -56.77% (Q3 2026) and -74.68% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Immunovant | 6.93 Bn | 6.93 Bn | - | -59.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -59.49% |
| Mar 31, 2026 | -50.32% |
| Dec 31, 2025 | -56.77% |
| Sep 30, 2025 | -74.68% |
| Jun 30, 2025 | -62.23% |
| Mar 31, 2025 | -69.14% |
| Dec 31, 2024 | -81.72% |
| Sep 30, 2024 | -58.44% |
| Jun 30, 2024 | -43.40% |
| Mar 31, 2024 | -37.64% |
| Dec 31, 2023 | -48.52% |
| Sep 30, 2023 | -79.36% |
| Jun 30, 2023 | -64.60% |
| Mar 31, 2023 | -48.94% |
| Dec 31, 2022 | -44.93% |
| Sep 30, 2022 | -39.89% |
| Jun 30, 2022 | -34.21% |
| Mar 31, 2022 | -29.61% |
| Dec 31, 2021 | -24.82% |
| Sep 30, 2021 | -26.84% |
API Access
Immunovant Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();